Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
The release of intracellular DNA into the extracellular area occurs via two pathways: cell death and active secretion by cells. The DNA, which is free in the extracellular space, is commonly known as Cell-Free DNA (cfDNA). In healthy people, the levels of cfDNA in the circulation are notably minimal...
Saved in:
Main Authors: | Fancheng Liu, Yazhen Su, Xinling Liu, Li Zhao, Zewen Wu, Yang Liu, Liyun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1537934/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01) -
Primer on the Rheumatic Diseases /
Published: (1993) -
South African Rheumatism and Arthritis Association 2024 updated guidelines for the management of rheumatoid arthritis
by: G Tarr, et al.
Published: (2024-09-01) -
The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
by: Mohamed Ismail Abdelkarem, et al.
Published: (2025-07-01) -
The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01)